Related Experiment Video
Updated: Jun 18, 2026

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
Published on: January 26, 2024
The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer
Evelien W Duiker1, Ate G J van der Zee, Pauline de Graeff
1Department of Medical Oncology, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands.
Objective:
Death ligand FasL, its agonistic receptor Fas, tumor necrosis factor related apoptosis inducing ligand (TRAIL) and its agonistic death receptors DR4 and DR5 are implied in carcinogenesis, tumor immune surveillance and response to chemotherapy. TRAIL receptor agonists are evaluated as anti-cancer agents. This study aimed to relate expression of death ligands/receptors and downstream initiator caspase 8 and its anti-apoptotic homologue FLICE like inhibitory protein (c-FLIP) in ovarian cancers to chemotherapy response and survival.
Methods:
Fas, FasL, TRAIL, DR4, DR5, caspase 8 and c-FLIP were determined immunohistochemically on a tissue microarray containing 382 ovarian cancers. Protein expression profiles were correlated with clinicopathologic variables, chemotherapy response and survival.
Results:
Most tumors expressed DR4, DR5, caspase 8 and c-FLIP. High c-FLIP expression was associated with expression of caspase 8 and both TRAIL receptors. TRAIL and Fas were associated with low tumor grade and better progression-free survival (HR 0.63, p=.018 and HR 0.54, p=.012), respectively, and Fas with disease-specific survival (HR 0.49, p=0.009) in univariate analysis.
Conclusions:
Fas and TRAIL loss is associated with dedifferentiation and worse prognosis. Expression of DR4, DR5, caspase 8 and c-FLIP by most ovarian cancers does not correlate with survival. High c-FLIP expression should be taken into account for death receptor targeted therapies.
Insights
Loss of Fas and TRAIL expression in ovarian cancer correlates with poorer prognosis and dedifferentiation. While most tumors express DR4, DR5, caspase 8, and c-FLIP, only Fas and TRAIL levels impact survival, suggesting targeted therapies should consider c-FLIP levels.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Death ligands (FasL, TRAIL) and their receptors (Fas, DR4, DR5) are implicated in cancer development, immune surveillance, and chemotherapy response.
- Tumor necrosis factor related apoptosis inducing ligand (TRAIL) receptor agonists are under investigation as anti-cancer therapeutics.
- Caspase 8 and its inhibitor c-FLIP play crucial roles in apoptosis signaling pathways relevant to cancer.
Purpose of the Study:
- To investigate the correlation between the expression of death pathway components (Fas, FasL, TRAIL, DR4, DR5, caspase 8, c-FLIP) in ovarian cancers.
- To determine the relationship between these molecular markers and patient response to chemotherapy.
- To assess the association of these markers with overall survival and progression-free survival in ovarian cancer patients.
Main Methods:
- Immunohistochemistry was employed to quantify the expression of Fas, FasL, TRAIL, DR4, DR5, caspase 8, and c-FLIP.
- Protein expression levels were analyzed on a tissue microarray comprising 382 ovarian cancer samples.
- Statistical correlations were performed between marker expression, clinicopathologic variables, chemotherapy response, and survival outcomes.
Main Results:
- High expression of c-FLIP was frequently observed and associated with caspase 8 and TRAIL receptor expression.
- Loss of TRAIL expression correlated with lower tumor grade and improved progression-free survival (HR 0.63).
- Loss of Fas expression was linked to better progression-free survival (HR 0.54) and disease-specific survival (HR 0.49), and associated with lower tumor grade.
Conclusions:
- Reduced expression of Fas and TRAIL in ovarian cancers is linked to dedifferentiation and a poorer prognosis.
- Widespread expression of DR4, DR5, caspase 8, and c-FLIP in ovarian cancers did not show a direct correlation with patient survival.
- The expression level of c-FLIP should be considered when developing targeted therapies aimed at death receptors in ovarian cancer treatment.
More Related Videos
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Caspases

